Tech Company Financing Transactions

Cadent Therapeutics Funding Round

Cadent Therapeutics closed a $40 million Series B financing round on 11/16/2018. Backers included Atlas Venture, Cowen Capital Partners and Access Industries.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

60 Hamilton St.
Cambridge, MA 02139
USA

Phone

Undisclosed

Website

www.cadenttx.com

Email Address

[email protected]

Overview

Cadent Therapeutics is creating breakthrough therapies for the treatment of movement disorders and cognitive impairment. The company combines target specificity, patient selection, drug design and optimization, and novel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jodie Morrison

        

Chief Financial Officer

John McBride

        

Chief Scientific Officer

Timothy Piser

        

President

Michael Curtis

        

VP - Product Management

Gregg Keaney

        

Browse more venture capital transactions:

Prev: 11/16/2018: Bunch venture capital transaction
Next: 11/16/2018: Shyft Technologies venture capital transaction

Share this article

About Database of VC Transactions

We do our best to record tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary